3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
14
Neoplasm Metastasis
8
Neoplasms
5
Carcinoma, Non-Small-Cell Lung
4
Stomach Neoplasms
3
Colorectal Neoplasms
3
Adenocarcinoma
3
Brain Neoplasms
2
Triple Negative Breast Neoplasms
1
Meningeal Carcinomatosis
1
HER2-mutant Non-Small Cell Lung Cancer
1
Gastrointestinal Neoplasms
1
Carcinoma, Transitional Cell
1
Interventions
Radiotherapy
2
Pyridoxine
2
Etoposide
2
Cytarabine
2
Cyclophosphamide
2
sodium thiosulfate
1
pegfilgrastim
1
pegaspargase
1
etoposide phosphate
1
Vincristine
1
Triptorelin Pamoate
1
Rituximab
1
Prednisolone
1
Methylprednisolone
1
Methotrexate
1
Mercaptopurine
1
Leucovorin
1
Hydrocortisone
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Doxorubicin
1
Dexrazoxane
1
Dexamethasone
1
Celecoxib
1
Carboplatin
1
Capecitabine
1
Asparaginase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Drug-Related Side Effects and Adverse Reactions
×
trastuzumab deruxtecan
×
Clear all
No trials found.